Overview

Omega-3 Fatty Acid for Critically Ill Patients.

Status:
Completed
Trial end date:
2017-11-30
Target enrollment:
Participant gender:
Summary
Sepsis is the most common reason for intensive care unit (ICU) admission. Sepsis flares up the systemic inflammatory response with its mediators. Sepsis treatment protocols have been established in many centres with immune nutrient as adjuvant treatment. Omega-3 fatty acid and other anti-oxidants formulae have been found to improve sepsis outcome. In most of the studies, immune nutrients were giving parenterally, however, nowadays the preferable route of feeding in critically ill patients is enterally. The present study was done to investigate the effect of enteral Omega-3 fatty acid in septic critically ill patients.
Phase:
N/A
Details
Lead Sponsor:
Menoufia University